Enzymes - Molecular Machines
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
290
NCT06545942
Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
Phase: Phase 1
Role: Lead Sponsor
Start: Aug 13, 2024
Completion: Nov 30, 2027
NCT06974110
Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors
Start: Jul 16, 2025
Completion: May 31, 2028
Loading map...